Teva Investigational Site 10493 — Normal, Illinois

Teva Investigational Site 10493 is a clinical research site located in Normal, Illinois, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Teva Investigational Site 10493 has participated in 1 clinical trials.

Therapeutic areas: Allergic Rhinitis.

Sponsors: Teva Branded Pharmaceutical Products R&D, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

• Advocate Health and Hospitals Corp
• Bromenn Regional Medical Center
• Community Cancer Center
• Carle Cancer Institute Normal
• Illinois CancerCare-Community Cancer Center
• Carle BroMenn Medical Center
• Community Cancer Center Foundation
• Sneeze, Wheeze & Itch Associates
• Sneeze Wheeze and Itch Associates
• Research Site
• GSK Investigational Site
• Midwest Allergy Sinus Asthma SC

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Teva Investigational Site 10493?

Teva Investigational Site 10493 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Teva Investigational Site 10493 conducted?

Teva Investigational Site 10493 has 1 clinical trials on record. Their work covers Allergic Rhinitis.

Is Teva Investigational Site 10493 accredited by Crixeo Clinical Trials?

Teva Investigational Site 10493 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Teva Investigational Site 10493?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.